cbdMD (YCBD) Return on Capital Employed Growth (3y) (2020 - 2025)
cbdMD (YCBD) Return on Capital Employed Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 480.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,902.00 |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 14,641.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14,641.00 |
| Sep 30, 2025 | 14,813.00 |
| Jun 30, 2025 | 7,514.00 |
| Mar 31, 2025 | -4,433.00 |
| Dec 31, 2024 | -8,261.00 |
| Sep 30, 2024 | -7,492.00 |
| Jun 30, 2024 | -27,196.00 |
| Mar 31, 2024 | -23,907.00 |
| Dec 31, 2023 | -18,971.00 |
| Sep 30, 2023 | -9,593.00 |
| Jun 30, 2023 | -5,991.00 |
| Mar 31, 2023 | -15,530.00 |
| Dec 31, 2022 | -15,340.00 |
| Sep 30, 2022 | -16,344.00 |
| Jun 30, 2022 | -8,847.00 |
| Mar 31, 2022 | -4,293.00 |
| Dec 31, 2021 | -3,787.00 |
| Sep 30, 2021 | -515.00 |
| Jun 30, 2021 | -1,988.00 |
| Mar 31, 2021 | -933.00 |